本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

iTeos Therapeutics

7.25
+0.40005.84%
盤後7.250.00000.00%19:35 EDT
成交量:81.67萬
成交額:581.68萬
市值:2.77億
市盈率:-2.35
高:7.30
開:6.79
低:6.61
收:6.85
資料載入中...
2024/03/06

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/06

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/16

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/11

重要事件披露

Form 8-K - Current report
2024/01/10

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/07

重要事件披露

Form 8-K - Current report
2023/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/24

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/26

重要事件披露

Form 8-K - Current report
2023/06/20

重要事件披露

Form 8-K - Current report
2023/05/17

SEC問詢函

Form CORRESP - Correspondence
2023/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/10

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals